Evidence map›Paper›PMID 24703895›Full record

ArticleFree radical biology & medicine2014

Involvement of Na/K-ATPase in hydrogen peroxide-induced activation of the Src/ERK pathway in LLC-PK1 cells.

Yu Wang, Qiqi Ye, Changxuan Liu, Jeffrey X Xie, Yanling Yan, Fangfang Lai, Qiming Duan, Xiaomei Li, Jiang Tian, Zijian Xie

Open access · greenAbstract read
In one paragraph

Article in Free radical biology & medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. pNaKtide Inhibits Na/K-ATPase Signaling and Attenuates Obesity.Journal of clinical and medical sciences · 2023
    Article
  12. Article
  13. Article
  14. Toxins · 2021
    Review
  15. Article
  16. NaMolecules (Basel, Switzerland) · 2021
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Yu WangRenal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Beijing, China.
Qiqi YeDepartment of Physiology and Department of Pharmacology and Medicine, College of Medicine, University of Toledo, Toledo, OH 43614, USA.
Changxuan LiuRenal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Beijing, China.
Jeffrey X XieDepartment of Physiology and Department of Pharmacology and Medicine, College of Medicine, University of Toledo, Toledo, OH 43614, USA.
Yanling YanDepartment of Physiology and Department of Pharmacology and Medicine, College of Medicine, University of Toledo, Toledo, OH 43614, USA.
Fangfang LaiDepartment of Physiology and Department of Pharmacology and Medicine, College of Medicine, University of Toledo, Toledo, OH 43614, USA.
Qiming DuanDepartment of Physiology and Department of Pharmacology and Medicine, College of Medicine, University of Toledo, Toledo, OH 43614, USA.
Xiaomei LiRenal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Beijing, China.
Jiang TianDepartment of Physiology and Department of Pharmacology and Medicine, College of Medicine, University of Toledo, Toledo, OH 43614, USA.
Zijian XieDepartment of Physiology and Department of Pharmacology and Medicine, College of Medicine, University of Toledo, Toledo, OH 43614, USA. Electronic address: Zi-jian.Xie@utoledo.edu.
University of Toledo · USPeking University · CNPeking University First Hospital · CN

Funding

Receptor Na/K-ATPase Antagonists As Novel Therapeutics For Renal/Cardiac DiseasesR01HL109015 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI SHAPIRO, JOSEPH ISAAC, XIE, ZIJIAN · 2011 to 2014
$2.2M
Na/K-ATPase Reduction in Renal Disease-Related Cardiac DysfunctionR01HL105649 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI TIAN, JIANG · 2012 to 2016
$1.8M
NHLBI NIH HHS HL-105649NHLBI NIH HHS HL-109015NHLBI NIH HHS R01 HL105649NHLBI NIH HHS R01 HL109015
6 · The paper itself

Abstract

We have shown that Na/K-ATPase interacts with Src. Here, we test the role of this interaction in H2O2-induced activation of Src and ERK. We found that exposure of LLC-PK1 cells to H2O2 generated by the addition of glucose oxidase into the culture medium activated Src and ERK1/2. It also caused a modest reduction in the number of surface Na/K-ATPases and in ouabain-sensitive Rb(+) uptake. These effects of H2O2 seem similar to those induced by ouabain, a specific ligand of Na/K-ATPase, in LLC-PK1 cells. In accordance, we found that the effects of H2O2 on Src and ERK1/2 were inhibited in α1 Na/K-ATPase-knockdown PY-17 cells. Whereas expression of wild-type α1 or the A420P mutant α1 defective in Src regulation rescued the pumping activity in PY-17 cells, only α1, and not the A420P mutant, was able to restore the H2O2-induced activation of protein kinases. Consistent with this, disrupting the formation of the Na/K-ATPase/Src complex with pNaKtide attenuated the effects of H2O2 on the kinases. Moreover, a direct effect of H2O2 on Na/K-ATPase-mediated regulation of Src was demonstrated. Finally, H2O2 reduced the expression of E-cadherin through the Na/K-ATPase/Src-mediated signaling pathway. Taken together, the data suggest that the Na/K-ATPase/Src complex may serve as one of the receptor mechanisms for H2O2 to regulate Src/ERK protein kinases and consequently the phenotype of renal epithelial cells.

Indexed as

AnimalsCadherinsEnzyme ActivationEnzyme InhibitorsGene Expression RegulationGlucoseHydrogen PeroxideLLC-PK1 CellsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3OuabainPhenotypeProtein SubunitsSignal TransductionSodium-Potassium-Exchanging ATPasesrc-Family KinasesCadherinsEnzyme InhibitorsGlucoseHydrogen PeroxideMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3OuabainProtein SubunitsSodium-Potassium-Exchanging ATPasesrc-Family KinasesERKFree radicalsHydrogen peroxideMutantNa/K-ATPaseSrc

Identifiers

PMID24703895
PMCPMC6779055
OpenAlexW2033792510

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.